Lexeo’s partnership with Cure has allowed us to further cement our footprint in New York City. Cure provides state of the art infrastructure and engagement with the broader life sciences community, helping foster meaningful relationships while growing this important biotech hub. Cure’s unique programming allows us to stay at the forefront of healthcare thought leadership and innovation.

R. Nolan Townsend, CEO, Lexeo Therapeutics

Integrating the Cure has truly been like entering the next stage for Wandercraft. It felt like suddenly being part of the ecosystem, meeting relevant people at every corner & on every floor. One week after moving in, we organized our keynote here at Cure. The whole team was so helpful curating the attendees list, but moreover they spontaneously helped making relevant intros to journalists after the event and secured national media coverage afterwards.

Matthieu Masselin, CEO, WanderCraft

The New York City biotech environment is one of the best in the world and Cure is at the forefront of this. Cure fills a gap in the industry by providing flexible working space in a warm and collaborative community for those companies without the size or resources for long term commercial leases. Cure is a critical partner supporting our mission of delivering breakthrough therapies for patients suffering from chronic inflammatory diseases. We love coming to work every day at Cure!

Kyle Carver, Chief Financial Officer, Evommune

We were introduced to CURE by Deerfield - one of our investors and partners - and the space, location, and collaborative energy immediately resonated with us. It has since become our NYC headquarters. We love the state-of-the-art design, numerous amenities, and one-of-kind meeting and event spaces with fantastic views. And being part of the CURE ecosystem puts us in close proximity to other innovative companies working at the intersection of healthcare and technology.

Insilico Medicine